---
source_pdf: "https://drive.google.com/file/d/1PZf8lvCKs9uoR8ASbo8p_2_YdsoWdzT7wr2cfc_A-dA/view"
drive_folder: "Portfolio/Amae"
type: portfolio
company: Amae
ingested: 2025-12-26
original_filename: "AMAE thoughts"
---

> **Original:** [View Original PDF](https://drive.google.com/file/d/1PZf8lvCKs9uoR8ASbo8p_2_YdsoWdzT7wr2cfc_A-dA/view)

Sending

ROI

Chipper

Lucia - Osmind

Bob and/or Scott

Why now

Institutional spend

R

Execution risk

$2m,

Multiple companies in the space

Firsthand

Mental health

Credible team in place

Contracting side - Bob

$15m round

Overview: $2.0M - $2.5M will give AMAE ample runway to sign first payer contract and lay foundation (product, payment sophistication, clinical model) for scale with subsequent round

Clinical model

Market size

Team

Competition

Firsthand

Valera

Apti Health

Mindstrong

Many others with mild/moderate DNA

ROI

Bundled payment examples

https://www.healthaffairs.org/do/10.1377/forefront.20181211.111071/full/

Capital requirements

Majority of capital is going to build out team and can be flexible to get contract (Stas says 6-9 months, likely longer)